MRK acquires VRNA for $107/sh cash—a 23% premium to yesterday’s close: https://finance.yahoo.com/news/merck-acquire-verona-pharma-expanding-103000032.html The nominal deal value is $10.0B. This is MRK’s largest acquisition since 2021.